AHR and cancer: In short, the exposome approach was able to capture a molecular signature of the exposure (altered fatty acid profiles) that points toward a causal pathway (AHR signaling and downstream metabolic changes) leading to potential health outcomes (e.g. elevated cancer risk, given the role of AHR in tumor promotion).